Related Experiment Video
Updated: Jun 8, 2025

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes.
Kevin R Nash1, Umesh K Jinwal2, Krishna Moorthi Bhat3
1Department of Molecular Pharmacology and Physiology, College of Medicine, University of South Florida, Tampa, FL, USA.
Ubiquitin ligase UBE3A is crucial for brain development and function. Reduced UBE3A levels may drive neurodegenerative diseases by increasing protein aggregation and cell death.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Post-translational modifications (PTMs) regulate protein function and disease.
- Ubiquitination, a key PTM, involves E3 ligases controlling protein fate.
- UBE3A, an E3 ligase, is linked to neurodevelopment and autism spectrum disorders (ASDs).
Purpose of the Study:
- To review the literature on UBE3A's role in neurodevelopment.
- To explore UBE3A's function in normal brain processes.
- To investigate UBE3A's involvement in neurodegenerative diseases.
Main Methods:
- Literature review of UBE3A.
- Analysis of UBE3A's role in proteinopathies.
- Examination of UBE3A's impact on cognitive function.
Main Results:
- UBE3A is vital for learning, memory, and neurodevelopment.
- Dysregulation of UBE3A is implicated in neurodevelopmental disorders like ASDs.
- Decreased UBE3A levels correlate with increased protein aggregation and cell death in neurodegeneration.
Conclusions:
- UBE3A plays a critical role in neurodevelopment and cognitive function.
- UBE3A dysregulation contributes to both neurodevelopmental and neurodegenerative diseases.
- Targeting UBE3A may offer therapeutic strategies for neurological disorders.
More Related Videos
10:45Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Related Concept Videos
The Blood-brain Barrier
Neurulation